WO2000003679A2 - Nutritionally active composition for hardening fingernails - Google Patents
Nutritionally active composition for hardening fingernails Download PDFInfo
- Publication number
- WO2000003679A2 WO2000003679A2 PCT/US1999/015669 US9915669W WO0003679A2 WO 2000003679 A2 WO2000003679 A2 WO 2000003679A2 US 9915669 W US9915669 W US 9915669W WO 0003679 A2 WO0003679 A2 WO 0003679A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- composition
- substituent
- substituents
- beverage
- psychological feedback
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 235
- 210000004905 finger nail Anatomy 0.000 title claims abstract description 22
- 230000007774 longterm Effects 0.000 claims abstract description 63
- 230000009286 beneficial effect Effects 0.000 claims abstract description 59
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 26
- 108010010803 Gelatin Proteins 0.000 claims abstract description 14
- 229920000159 gelatin Polymers 0.000 claims abstract description 14
- 239000008273 gelatin Substances 0.000 claims abstract description 14
- 235000019322 gelatine Nutrition 0.000 claims abstract description 14
- 235000011852 gelatine desserts Nutrition 0.000 claims abstract description 14
- 239000000377 silicon dioxide Substances 0.000 claims abstract description 13
- 235000013361 beverage Nutrition 0.000 claims description 76
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 claims description 60
- 244000299461 Theobroma cacao Species 0.000 claims description 51
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 32
- LOUPRKONTZGTKE-WZBLMQSHSA-N Quinine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-WZBLMQSHSA-N 0.000 claims description 31
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 claims description 30
- 229960001948 caffeine Drugs 0.000 claims description 30
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 claims description 30
- 239000000284 extract Substances 0.000 claims description 30
- 235000009470 Theobroma cacao Nutrition 0.000 claims description 26
- LGEQQWMQCRIYKG-DOFZRALJSA-N anandamide Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)NCCO LGEQQWMQCRIYKG-DOFZRALJSA-N 0.000 claims description 26
- LGEQQWMQCRIYKG-UHFFFAOYSA-N arachidonic acid ethanolamide Natural products CCCCCC=CCC=CCC=CCC=CCCCC(=O)NCCO LGEQQWMQCRIYKG-UHFFFAOYSA-N 0.000 claims description 26
- 235000019219 chocolate Nutrition 0.000 claims description 25
- 241000157855 Cinchona Species 0.000 claims description 24
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 24
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 claims description 24
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 claims description 24
- 239000011701 zinc Substances 0.000 claims description 22
- 240000000143 Turnera diffusa Species 0.000 claims description 21
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 21
- 235000004952 turnera diffusa Nutrition 0.000 claims description 21
- 229910052725 zinc Inorganic materials 0.000 claims description 21
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 claims description 20
- 241000218182 Eschscholzia Species 0.000 claims description 20
- 229960003692 gamma aminobutyric acid Drugs 0.000 claims description 20
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims description 20
- GPTFURBXHJWNHR-UHFFFAOYSA-N protopine Chemical compound C1=C2C(=O)CC3=CC=C4OCOC4=C3CN(C)CCC2=CC2=C1OCO2 GPTFURBXHJWNHR-UHFFFAOYSA-N 0.000 claims description 20
- LDCYZAJDBXYCGN-VIFPVBQESA-N 5-hydroxy-L-tryptophan Chemical compound C1=C(O)C=C2C(C[C@H](N)C(O)=O)=CNC2=C1 LDCYZAJDBXYCGN-VIFPVBQESA-N 0.000 claims description 19
- 229940000681 5-hydroxytryptophan Drugs 0.000 claims description 19
- 240000004371 Panax ginseng Species 0.000 claims description 19
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 19
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 19
- 241000234314 Zingiber Species 0.000 claims description 19
- 235000006886 Zingiber officinale Nutrition 0.000 claims description 19
- 235000008397 ginger Nutrition 0.000 claims description 19
- 235000008434 ginseng Nutrition 0.000 claims description 19
- LDCYZAJDBXYCGN-UHFFFAOYSA-N oxitriptan Natural products C1=C(O)C=C2C(CC(N)C(O)=O)=CNC2=C1 LDCYZAJDBXYCGN-UHFFFAOYSA-N 0.000 claims description 19
- 230000036642 wellbeing Effects 0.000 claims description 19
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims description 18
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Chemical compound OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims description 18
- 235000008694 Humulus lupulus Nutrition 0.000 claims description 17
- 244000025221 Humulus lupulus Species 0.000 claims description 17
- 235000015203 fruit juice Nutrition 0.000 claims description 17
- 235000001258 Cinchona calisaya Nutrition 0.000 claims description 16
- 241000218671 Ephedra Species 0.000 claims description 16
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims description 16
- LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 claims description 16
- 229960000948 quinine Drugs 0.000 claims description 16
- YAPQBXQYLJRXSA-UHFFFAOYSA-N theobromine Chemical compound CN1C(=O)NC(=O)C2=C1N=CN2C YAPQBXQYLJRXSA-UHFFFAOYSA-N 0.000 claims description 16
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 14
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims description 14
- 235000015192 vegetable juice Nutrition 0.000 claims description 14
- 241000195955 Equisetum hyemale Species 0.000 claims description 13
- 229930091371 Fructose Natural products 0.000 claims description 12
- 239000005715 Fructose Substances 0.000 claims description 12
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 12
- 229940076279 serotonin Drugs 0.000 claims description 12
- 229960000278 theophylline Drugs 0.000 claims description 12
- INPQIVHQSQUEAJ-UHFFFAOYSA-N 5-fluorotryptophan Chemical compound C1=C(F)C=C2C(CC(N)C(O)=O)=CNC2=C1 INPQIVHQSQUEAJ-UHFFFAOYSA-N 0.000 claims description 11
- 206010016334 Feeling hot Diseases 0.000 claims description 11
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 11
- 241000208672 Lobelia Species 0.000 claims description 11
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 11
- 239000011777 magnesium Substances 0.000 claims description 11
- 229910052749 magnesium Inorganic materials 0.000 claims description 11
- 235000013336 milk Nutrition 0.000 claims description 11
- 210000004080 milk Anatomy 0.000 claims description 11
- YMEXGEAJNZRQEH-UHFFFAOYSA-N 6-Fluoro-DL-tryptophan Chemical compound FC1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 YMEXGEAJNZRQEH-UHFFFAOYSA-N 0.000 claims description 10
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 claims description 10
- 235000003097 Artemisia absinthium Nutrition 0.000 claims description 10
- 240000001851 Artemisia dracunculus Species 0.000 claims description 10
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 claims description 10
- OWNRRUFOJXFKCU-UHFFFAOYSA-N Bromadiolone Chemical compound C=1C=C(C=2C=CC(Br)=CC=2)C=CC=1C(O)CC(C=1C(OC2=CC=CC=C2C=1O)=O)C1=CC=CC=C1 OWNRRUFOJXFKCU-UHFFFAOYSA-N 0.000 claims description 10
- 235000002567 Capsicum annuum Nutrition 0.000 claims description 10
- 240000004160 Capsicum annuum Species 0.000 claims description 10
- 235000005979 Citrus limon Nutrition 0.000 claims description 10
- 244000131522 Citrus pyriformis Species 0.000 claims description 10
- 244000228088 Cola acuminata Species 0.000 claims description 10
- 241001071795 Gentiana Species 0.000 claims description 10
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 10
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 10
- 244000141009 Hypericum perforatum Species 0.000 claims description 10
- 235000017309 Hypericum perforatum Nutrition 0.000 claims description 10
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims description 10
- 241001293495 Lactuca virosa Species 0.000 claims description 10
- 244000021273 Peumus boldus Species 0.000 claims description 10
- GTRPODKMSBFDOI-UHFFFAOYSA-N Protopine Natural products CN1Cc2c3OCOc3ccc2C4C1Cc5cc6OCOc6cc5C4=O GTRPODKMSBFDOI-UHFFFAOYSA-N 0.000 claims description 10
- ZAALQOFZFANFTF-UHFFFAOYSA-N Pseudoprotipine Natural products C1=C2C(=O)CC3=CC=4OCOC=4C=C3CN(C)CCC2=CC2=C1OCO2 ZAALQOFZFANFTF-UHFFFAOYSA-N 0.000 claims description 10
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 10
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 10
- 229930006000 Sucrose Natural products 0.000 claims description 10
- 244000269722 Thea sinensis Species 0.000 claims description 10
- 235000009206 Turnera diffusa Nutrition 0.000 claims description 10
- 239000001138 artemisia absinthium Substances 0.000 claims description 10
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 claims description 10
- CHWPMFMUQATVNK-ARYYTZDLSA-N dihydrosporogen AO-1 Natural products O[C@H]1[C@]2(C(C)=C)O[C@@H]2[C@]2(C)[C@@H](C)[C@H](O)CCC2=C1 CHWPMFMUQATVNK-ARYYTZDLSA-N 0.000 claims description 10
- 239000003623 enhancer Substances 0.000 claims description 10
- 229960002179 ephedrine Drugs 0.000 claims description 10
- 239000008103 glucose Substances 0.000 claims description 10
- 239000008267 milk Substances 0.000 claims description 10
- 229950010450 pseudophedrine Drugs 0.000 claims description 10
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims description 10
- 239000005720 sucrose Substances 0.000 claims description 10
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 claims description 9
- 229930182837 (R)-adrenaline Natural products 0.000 claims description 9
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 9
- 235000016795 Cola Nutrition 0.000 claims description 9
- 229930182816 L-glutamine Natural products 0.000 claims description 9
- 235000007189 Oryza longistaminata Nutrition 0.000 claims description 9
- 240000007594 Oryza sativa Species 0.000 claims description 9
- 235000007164 Oryza sativa Nutrition 0.000 claims description 9
- 235000016787 Piper methysticum Nutrition 0.000 claims description 9
- 240000005546 Piper methysticum Species 0.000 claims description 9
- 235000010841 Silybum marianum Nutrition 0.000 claims description 9
- 241000245665 Taraxacum Species 0.000 claims description 9
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims description 9
- 229910052791 calcium Inorganic materials 0.000 claims description 9
- 239000011575 calcium Substances 0.000 claims description 9
- 229960005139 epinephrine Drugs 0.000 claims description 9
- 235000009569 green tea Nutrition 0.000 claims description 9
- NGVDGCNFYWLIFO-UHFFFAOYSA-N pyridoxal 5'-phosphate Chemical compound CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O NGVDGCNFYWLIFO-UHFFFAOYSA-N 0.000 claims description 9
- 235000007682 pyridoxal 5'-phosphate Nutrition 0.000 claims description 9
- 239000011589 pyridoxal 5'-phosphate Substances 0.000 claims description 9
- 229960001327 pyridoxal phosphate Drugs 0.000 claims description 9
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims description 8
- 240000000073 Achillea millefolium Species 0.000 claims description 8
- 235000007754 Achillea millefolium Nutrition 0.000 claims description 8
- 244000205574 Acorus calamus Species 0.000 claims description 8
- 244000061520 Angelica archangelica Species 0.000 claims description 8
- 240000006891 Artemisia vulgaris Species 0.000 claims description 8
- 235000011996 Calamus deerratus Nutrition 0.000 claims description 8
- 235000005747 Carum carvi Nutrition 0.000 claims description 8
- 240000000467 Carum carvi Species 0.000 claims description 8
- 240000003538 Chamaemelum nobile Species 0.000 claims description 8
- 235000007866 Chamaemelum nobile Nutrition 0.000 claims description 8
- 235000021513 Cinchona Nutrition 0.000 claims description 8
- 244000223760 Cinnamomum zeylanicum Species 0.000 claims description 8
- 244000183685 Citrus aurantium Species 0.000 claims description 8
- 235000007716 Citrus aurantium Nutrition 0.000 claims description 8
- 235000007856 Cnicus benedictus Nutrition 0.000 claims description 8
- 244000155563 Cnicus benedictus Species 0.000 claims description 8
- 235000004185 Hyptis suaveolens Nutrition 0.000 claims description 8
- 235000008227 Illicium verum Nutrition 0.000 claims description 8
- 240000007232 Illicium verum Species 0.000 claims description 8
- 235000002598 Inula helenium Nutrition 0.000 claims description 8
- 244000116484 Inula helenium Species 0.000 claims description 8
- 244000137850 Marrubium vulgare Species 0.000 claims description 8
- 235000005321 Marrubium vulgare Nutrition 0.000 claims description 8
- 235000007232 Matricaria chamomilla Nutrition 0.000 claims description 8
- 235000010654 Melissa officinalis Nutrition 0.000 claims description 8
- 244000062730 Melissa officinalis Species 0.000 claims description 8
- 244000246386 Mentha pulegium Species 0.000 claims description 8
- 235000016257 Mentha pulegium Nutrition 0.000 claims description 8
- 235000004357 Mentha x piperita Nutrition 0.000 claims description 8
- 235000011779 Menyanthes trifoliata Nutrition 0.000 claims description 8
- 240000008821 Menyanthes trifoliata Species 0.000 claims description 8
- 235000000556 Paullinia cupana Nutrition 0.000 claims description 8
- 240000003444 Paullinia cupana Species 0.000 claims description 8
- 240000003085 Quassia amara Species 0.000 claims description 8
- 235000009694 Quassia amara Nutrition 0.000 claims description 8
- 244000178231 Rosmarinus officinalis Species 0.000 claims description 8
- 240000007164 Salvia officinalis Species 0.000 claims description 8
- 244000223014 Syzygium aromaticum Species 0.000 claims description 8
- 235000016639 Syzygium aromaticum Nutrition 0.000 claims description 8
- 235000007303 Thymus vulgaris Nutrition 0.000 claims description 8
- 240000002657 Thymus vulgaris Species 0.000 claims description 8
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 8
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 claims description 8
- 229940046374 chromium picolinate Drugs 0.000 claims description 8
- 229940060736 chromium polynicotinate Drugs 0.000 claims description 8
- GJYSUGXFENSLOO-UHFFFAOYSA-N chromium;pyridine-2-carboxylic acid Chemical compound [Cr].OC(=O)C1=CC=CC=N1.OC(=O)C1=CC=CC=N1.OC(=O)C1=CC=CC=N1 GJYSUGXFENSLOO-UHFFFAOYSA-N 0.000 claims description 8
- 235000017803 cinnamon Nutrition 0.000 claims description 8
- 235000003599 food sweetener Nutrition 0.000 claims description 8
- 235000019534 high fructose corn syrup Nutrition 0.000 claims description 8
- 235000001050 hortel pimenta Nutrition 0.000 claims description 8
- 239000000865 liniment Substances 0.000 claims description 8
- 239000001630 malic acid Substances 0.000 claims description 8
- 235000011090 malic acid Nutrition 0.000 claims description 8
- 210000003516 pericardium Anatomy 0.000 claims description 8
- 229940013788 quassia Drugs 0.000 claims description 8
- 235000005412 red sage Nutrition 0.000 claims description 8
- 239000003765 sweetening agent Substances 0.000 claims description 8
- 239000001585 thymus vulgaris Substances 0.000 claims description 8
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical group OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 6
- NHWZQIYTQZEOSJ-UHFFFAOYSA-N carbonic acid;phosphoric acid Chemical compound OC(O)=O.OP(O)(O)=O NHWZQIYTQZEOSJ-UHFFFAOYSA-N 0.000 claims description 6
- 235000020688 green tea extract Nutrition 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 230000001953 sensory effect Effects 0.000 claims description 6
- 229960004441 tyrosine Drugs 0.000 claims description 6
- 229940094952 green tea extract Drugs 0.000 claims description 5
- 244000144730 Amygdalus persica Species 0.000 claims description 4
- 241000167854 Bourreria succulenta Species 0.000 claims description 4
- 241000220225 Malus Species 0.000 claims description 4
- 235000011430 Malus pumila Nutrition 0.000 claims description 4
- 235000015103 Malus silvestris Nutrition 0.000 claims description 4
- 235000006040 Prunus persica var persica Nutrition 0.000 claims description 4
- 240000001717 Vaccinium macrocarpon Species 0.000 claims description 4
- 235000012545 Vaccinium macrocarpon Nutrition 0.000 claims description 4
- 244000078534 Vaccinium myrtillus Species 0.000 claims description 4
- 235000002118 Vaccinium oxycoccus Nutrition 0.000 claims description 4
- 235000009754 Vitis X bourquina Nutrition 0.000 claims description 4
- 235000012333 Vitis X labruscana Nutrition 0.000 claims description 4
- 240000006365 Vitis vinifera Species 0.000 claims description 4
- 235000014787 Vitis vinifera Nutrition 0.000 claims description 4
- 235000019693 cherries Nutrition 0.000 claims description 4
- 235000004634 cranberry Nutrition 0.000 claims description 4
- 235000013399 edible fruits Nutrition 0.000 claims description 4
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 3
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 2
- 244000099147 Ananas comosus Species 0.000 claims description 2
- 235000007119 Ananas comosus Nutrition 0.000 claims description 2
- 108010011485 Aspartame Proteins 0.000 claims description 2
- 235000008733 Citrus aurantifolia Nutrition 0.000 claims description 2
- 240000000560 Citrus x paradisi Species 0.000 claims description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 2
- 235000016623 Fragaria vesca Nutrition 0.000 claims description 2
- 240000009088 Fragaria x ananassa Species 0.000 claims description 2
- 235000011363 Fragaria x ananassa Nutrition 0.000 claims description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 2
- 240000005561 Musa balbisiana Species 0.000 claims description 2
- 235000018290 Musa x paradisiaca Nutrition 0.000 claims description 2
- 235000014443 Pyrus communis Nutrition 0.000 claims description 2
- 240000001987 Pyrus communis Species 0.000 claims description 2
- 235000017848 Rubus fruticosus Nutrition 0.000 claims description 2
- 235000011941 Tilia x europaea Nutrition 0.000 claims description 2
- 240000006909 Tilia x europaea Species 0.000 claims description 2
- 235000003095 Vaccinium corymbosum Nutrition 0.000 claims description 2
- 235000017537 Vaccinium myrtillus Nutrition 0.000 claims description 2
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 claims description 2
- 239000000605 aspartame Substances 0.000 claims description 2
- 235000010357 aspartame Nutrition 0.000 claims description 2
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical group OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims description 2
- 229960003438 aspartame Drugs 0.000 claims description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims description 2
- 235000021029 blackberry Nutrition 0.000 claims description 2
- 235000021014 blueberries Nutrition 0.000 claims description 2
- HCAJEUSONLESMK-UHFFFAOYSA-N cyclohexylsulfamic acid Chemical compound OS(=O)(=O)NC1CCCCC1 HCAJEUSONLESMK-UHFFFAOYSA-N 0.000 claims description 2
- 229930182830 galactose Natural products 0.000 claims description 2
- 239000008101 lactose Substances 0.000 claims description 2
- 239000004571 lime Substances 0.000 claims description 2
- 235000019204 saccharin Nutrition 0.000 claims description 2
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 claims description 2
- 229940081974 saccharin Drugs 0.000 claims description 2
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 claims description 2
- 239000000600 sorbitol Substances 0.000 claims description 2
- 125000001424 substituent group Chemical group 0.000 claims 101
- 229960004799 tryptophan Drugs 0.000 claims 7
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims 2
- QDGAVODICPCDMU-UHFFFAOYSA-N 2-amino-3-[3-[bis(2-chloroethyl)amino]phenyl]propanoic acid Chemical compound OC(=O)C(N)CC1=CC=CC(N(CCCl)CCCl)=C1 QDGAVODICPCDMU-UHFFFAOYSA-N 0.000 claims 1
- 235000010205 Cola acuminata Nutrition 0.000 claims 1
- 235000015438 Cola nitida Nutrition 0.000 claims 1
- QVDSEJDULKLHCG-UHFFFAOYSA-N Psilocybine Natural products C1=CC(OP(O)(O)=O)=C2C(CCN(C)C)=CNC2=C1 QVDSEJDULKLHCG-UHFFFAOYSA-N 0.000 claims 1
- 125000005586 carbonic acid group Chemical group 0.000 claims 1
- 229940109275 cyclamate Drugs 0.000 claims 1
- BJHIKXHVCXFQLS-UYFOZJQFSA-N fructose group Chemical group OCC(=O)[C@@H](O)[C@H](O)[C@H](O)CO BJHIKXHVCXFQLS-UYFOZJQFSA-N 0.000 claims 1
- 229960002989 glutamic acid Drugs 0.000 claims 1
- QKTAAWLCLHMUTJ-UHFFFAOYSA-N psilocybin Chemical compound C1C=CC(OP(O)(O)=O)=C2C(CCN(C)C)=CN=C21 QKTAAWLCLHMUTJ-UHFFFAOYSA-N 0.000 claims 1
- 125000003410 quininyl group Chemical group 0.000 claims 1
- -1 horsehair Substances 0.000 abstract description 6
- 235000019441 ethanol Nutrition 0.000 description 19
- 235000016804 zinc Nutrition 0.000 description 12
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 235000001055 magnesium Nutrition 0.000 description 7
- RTAPDZBZLSXHQQ-UHFFFAOYSA-N 8-methyl-3,7-dihydropurine-2,6-dione Chemical class N1C(=O)NC(=O)C2=C1N=C(C)N2 RTAPDZBZLSXHQQ-UHFFFAOYSA-N 0.000 description 6
- 235000016709 nutrition Nutrition 0.000 description 6
- 230000004800 psychological effect Effects 0.000 description 6
- 235000015165 citric acid Nutrition 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- PFWLFWPASULGAN-UHFFFAOYSA-N 7-methylxanthine Chemical compound N1C(=O)NC(=O)C2=C1N=CN2C PFWLFWPASULGAN-UHFFFAOYSA-N 0.000 description 4
- 239000001569 carbon dioxide Substances 0.000 description 4
- 229910002092 carbon dioxide Inorganic materials 0.000 description 4
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 description 4
- 239000011707 mineral Substances 0.000 description 4
- 239000002831 pharmacologic agent Substances 0.000 description 4
- 229960004559 theobromine Drugs 0.000 description 4
- 230000037317 transdermal delivery Effects 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 240000007087 Apium graveolens Species 0.000 description 3
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 description 3
- 235000010591 Appio Nutrition 0.000 description 3
- 244000000626 Daucus carota Species 0.000 description 3
- 235000002767 Daucus carota Nutrition 0.000 description 3
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 3
- 229960001231 choline Drugs 0.000 description 3
- 239000011651 chromium Substances 0.000 description 3
- 235000008504 concentrate Nutrition 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 235000015872 dietary supplement Nutrition 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 235000008216 herbs Nutrition 0.000 description 3
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 3
- 229960000367 inositol Drugs 0.000 description 3
- 239000007937 lozenge Substances 0.000 description 3
- 239000000419 plant extract Substances 0.000 description 3
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 239000006188 syrup Substances 0.000 description 3
- 235000020357 syrup Nutrition 0.000 description 3
- 235000013311 vegetables Nutrition 0.000 description 3
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical class O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 235000004032 Centella asiatica Nutrition 0.000 description 2
- 244000146462 Centella asiatica Species 0.000 description 2
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 2
- 235000011824 Cola pachycarpa Nutrition 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 240000002045 Guettarda speciosa Species 0.000 description 2
- FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
- 229930195722 L-methionine Natural products 0.000 description 2
- 240000004658 Medicago sativa Species 0.000 description 2
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 description 2
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 229930003316 Vitamin D Natural products 0.000 description 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 2
- 229930003448 Vitamin K Natural products 0.000 description 2
- 229940121363 anti-inflammatory agent Drugs 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 239000007910 chewable tablet Substances 0.000 description 2
- 229910052804 chromium Inorganic materials 0.000 description 2
- 235000020971 citrus fruits Nutrition 0.000 description 2
- 238000001784 detoxification Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 229960000304 folic acid Drugs 0.000 description 2
- 235000019152 folic acid Nutrition 0.000 description 2
- 239000011724 folic acid Substances 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- 229960004452 methionine Drugs 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- 235000011007 phosphoric acid Nutrition 0.000 description 2
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 235000019615 sensations Nutrition 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 2
- 235000019166 vitamin D Nutrition 0.000 description 2
- 239000011710 vitamin D Substances 0.000 description 2
- 150000003710 vitamin D derivatives Chemical class 0.000 description 2
- 235000019168 vitamin K Nutrition 0.000 description 2
- 239000011712 vitamin K Substances 0.000 description 2
- 150000003721 vitamin K derivatives Chemical class 0.000 description 2
- 229940046008 vitamin d Drugs 0.000 description 2
- 229940046010 vitamin k Drugs 0.000 description 2
- 229940032991 zinc picolinate Drugs 0.000 description 2
- NHVUUBRKFZWXRN-UHFFFAOYSA-L zinc;pyridine-2-carboxylate Chemical compound C=1C=CC=NC=1C(=O)O[Zn]OC(=O)C1=CC=CC=N1 NHVUUBRKFZWXRN-UHFFFAOYSA-L 0.000 description 2
- ZMJBYMUCKBYSCP-UHFFFAOYSA-N (+)-Erythro-hydroxycitric acid Natural products OC(=O)C(O)C(O)(C(O)=O)CC(O)=O ZMJBYMUCKBYSCP-UHFFFAOYSA-N 0.000 description 1
- ZMJBYMUCKBYSCP-AWFVSMACSA-N (1s,2r)-1,2-dihydroxypropane-1,2,3-tricarboxylic acid Chemical compound OC(=O)[C@@H](O)[C@@](O)(C(O)=O)CC(O)=O ZMJBYMUCKBYSCP-AWFVSMACSA-N 0.000 description 1
- PWKSKIMOESPYIA-UHFFFAOYSA-N 2-acetamido-3-sulfanylpropanoic acid Chemical compound CC(=O)NC(CS)C(O)=O PWKSKIMOESPYIA-UHFFFAOYSA-N 0.000 description 1
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 1
- 240000002767 Acer grandidentatum Species 0.000 description 1
- 235000010319 Acer grandidentatum Nutrition 0.000 description 1
- 235000010328 Acer nigrum Nutrition 0.000 description 1
- 235000002629 Acer saccharinum Nutrition 0.000 description 1
- 235000010157 Acer saccharum subsp saccharum Nutrition 0.000 description 1
- 208000007848 Alcoholism Diseases 0.000 description 1
- 235000016068 Berberis vulgaris Nutrition 0.000 description 1
- 241000335053 Beta vulgaris Species 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- COLNVLDHVKWLRT-MRVPVSSYSA-N D-phenylalanine Chemical compound OC(=O)[C@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-MRVPVSSYSA-N 0.000 description 1
- 229930182832 D-phenylalanine Natural products 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 235000008100 Ginkgo biloba Nutrition 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- 235000009421 Myristica fragrans Nutrition 0.000 description 1
- 244000270834 Myristica fragrans Species 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 241000722363 Piper Species 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 235000015422 Rumex crispus ssp. crispus Nutrition 0.000 description 1
- 235000015426 Rumex crispus ssp. fauriei Nutrition 0.000 description 1
- 244000207667 Rumex vesicarius Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 241000533293 Sesbania emerus Species 0.000 description 1
- 241000320380 Silybum Species 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- AUYYCJSJGJYCDS-LBPRGKRZSA-N Thyrolar Chemical class IC1=CC(C[C@H](N)C(O)=O)=CC(I)=C1OC1=CC=C(O)C(I)=C1 AUYYCJSJGJYCDS-LBPRGKRZSA-N 0.000 description 1
- 235000009499 Vanilla fragrans Nutrition 0.000 description 1
- 244000263375 Vanilla tahitensis Species 0.000 description 1
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003537 Vitamin B3 Natural products 0.000 description 1
- 229930003571 Vitamin B5 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 201000007930 alcohol dependence Diseases 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 229940069428 antacid Drugs 0.000 description 1
- 239000003159 antacid agent Substances 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 235000019677 berry fruit juice Nutrition 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000011260 co-administration Methods 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229940050549 fiber Drugs 0.000 description 1
- 235000021564 flavored carbonated beverage Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229960002743 glutamine Drugs 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 235000012171 hot beverage Nutrition 0.000 description 1
- 239000005555 hypertensive agent Substances 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 239000008141 laxative Substances 0.000 description 1
- 229940125722 laxative agent Drugs 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 229940091250 magnesium supplement Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 229940035363 muscle relaxants Drugs 0.000 description 1
- 239000003158 myorelaxant agent Substances 0.000 description 1
- 210000000282 nail Anatomy 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- 235000019520 non-alcoholic beverage Nutrition 0.000 description 1
- 235000013615 non-nutritive sweetener Nutrition 0.000 description 1
- 239000001702 nutmeg Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000019533 nutritive sweetener Nutrition 0.000 description 1
- 239000011236 particulate material Substances 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- WVWHRXVVAYXKDE-UHFFFAOYSA-N piperine Natural products O=C(C=CC=Cc1ccc2OCOc2c1)C3CCCCN3 WVWHRXVVAYXKDE-UHFFFAOYSA-N 0.000 description 1
- MXXWOMGUGJBKIW-YPCIICBESA-N piperine Chemical compound C=1C=C2OCOC2=CC=1/C=C/C=C/C(=O)N1CCCCC1 MXXWOMGUGJBKIW-YPCIICBESA-N 0.000 description 1
- 229940075559 piperine Drugs 0.000 description 1
- 235000019100 piperine Nutrition 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 239000003507 refrigerant Substances 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 235000013533 rum Nutrition 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 235000011649 selenium Nutrition 0.000 description 1
- 229940091258 selenium supplement Drugs 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 235000014214 soft drink Nutrition 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 235000013322 soy milk Nutrition 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 235000012069 sugar maple Nutrition 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000005495 thyroid hormone Substances 0.000 description 1
- 229940036555 thyroid hormone Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 210000003371 toe Anatomy 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019160 vitamin B3 Nutrition 0.000 description 1
- 239000011708 vitamin B3 Substances 0.000 description 1
- 235000009492 vitamin B5 Nutrition 0.000 description 1
- 239000011675 vitamin B5 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Definitions
- T e invention relates to compositions having nutritionally beneficial substituents for hardening fingernails and substituents that stimulate short and/or long term psychological feedback.
- the invention also relates to vehicles or devices that accomplish the delivery of the nutritionally beneficial substituents to a recipient.
- the invention particularly concerns compositions for oral or translingual delivery using beverages, lozenges and the like as vehicles to facilitate delivery.
- the invention additionally concerns the use of transdermal delivery devices (e.g., patches) to accomplish the delivery of such substituent(s).
- the invention particularly concerns a formulated, substantially alcohol-free beverage for oral consumption having a nutritionally beneficial substituent and a substituent that stimulates psychological feedback and which accomplishes the oral delivery of the nutritionally beneficial substituent.
- Patent 5,626,849 (Hastings et al.) concerns a composition for facilitating weight loss.
- the composition contains chromium, L-camitine, • y-linolenic acid, (-) hydroxycitric acid, choline, inositol, antioxidants and herbs.
- U.S. Patent 5,567,424 (Hastings) describes a beverage composition containing herbs, fiber, antioxidants and enzymes.
- U.S. Patent 5,536,506 (Majeed et al.) describes piperine-containing compositions.
- U.S. Patent 5,571,441 (Andon et al.) is directed to nutritional supplements compositions that provide psychological feedback.
- the disclosed compositions contain vitamins and/or minerals as well as xanthine alkaloids (such as caffeine, etc.) that provide a physiological signal.
- U.S. Patent 5,114,723 (Stray-Gundersen) concerns hypotonic beverages for supplying physiologically essential electrolytes, nutrient minerals, carbohydrates and other ingredients to a consumer.
- Patent 4,992,282 (Mehansho et al.) concerns vitamin and mineral-fortified beverages, which may be supplemented with caffeine.
- U.S. Patent 4,612,205 (Kupper et al.) concerns fruit- flavored carbonated beverages that may be supplemented with caffeine.
- U.S. Patent 4,061,797 (Hannan, Jr. et al.) concerns non-carbonated, caffeinated fruit beverages.
- U.S. Patent 4,737,375 (Nakel et al.) describes calcium-supplemented beverages.
- U.S. Patent 4,769,244 (Lavie) describes non-hygroscopic water-soluble pulverulent compositions that may be employed to make beverages.
- compositions for accomplishing transdermal delivery of pharmaceuticals have also been described (see, for example, U.S. Patents 5,718,914 (Foldvari), 5,698,217 (Wilking), 5,721,257 (Baker), 5,683,713 (Blank etal.), and 4,788,189 (Glazer)).
- the present invention provides an improved composition for accomplishing the delivery of nutritionally beneficial substituents for hardening fingernails.
- the present invention additionally provides an improved formulated beverage that provides at least one, and most preferably multiple, short and long term psychological feedback(s) to the consumer.
- the present invention provides beverages and other compositions for hardening fingernails that are formulated to provide internal appeal directly to the brain (i.e., brain rewards).
- the present invention thus relates to a formulated, defined composition having a nutritionally beneficial substituent for hardening fingernails and a long and/or short term substituent that stimulates psychological feedback and to vehicles or devices that accomplish the delivery of the nutritionally beneficial substituent.
- Such preferred compositions will typically possess a nutritionally beneficial substituent and both a long term and a short term substituent that stimulates psychological feedback and which accomplishes the delivery of the nutritionally beneficial substituent.
- Preferred vehicles include oral and/or translingual delivery vehicles, such as beverages, elixirs, lozenges, chewable tablets, and the like, and transdermal delivery devices such as patches, bandages, etc.
- transdermal delivery devices such as patches, bandages, etc.
- fingernail is intended to encompass the nails of the fingers and toes.
- the invention concerns a composition (such as a beverage, etc.) for human consumption, comprising: at least one nutritionally beneficial substituent (A) selected from the group consisting of: gelatin; horsetail; silica; and bioavailable zinc; the substituent present in an amount sufficient to enhance or facilitate hardening of fingernails; and at least one additional substituent (B) that provides traditional psychological feedback selected from the group consisting of: caffeine or a caffeine equivalent; tryptophan; ephedra; cola; green tea extract; carbonic acid; phosphoric acid; citric acid; hops; cocoa; chocolate; an anandamide; quinine; malic acid; a sweetener; a fruit juice or fruit juice extract; milk; a vegetable juice or vegetable juice extract; and 5-hydroxy-tryptophan; present in an amount sufficient to provide a sensory psychological feedback.
- A nutritionally beneficial substituent
- B that provides traditional psychological feedback selected from the group consisting of: caffeine or a caffeine equivalent; tryptophan; ephedra; cola; green
- compositions that additionally contain at least one additional substituent (C) that provides long term psychological feedback substituent or at least one additional substituent (D) that provides short term psychological feedback; wherein the substituent (C) that provides the long term psychological feedback is selected from the group consisting of: an anandamide; 5-hydroxytryptophan; 5-fluoro-A- methyltryptamine; 5-fluorotryptophan; 6-fluorotryptophan; tryptophan; aliocryptine; caffeine; theophylline; theobromine; California poppy; calcium; chromium picolinate; chromium polynicotinate; chicalote extract; cocoa; chocolate; Damiana
- Johnswort and is present in an amount sufficient to provide a long term feeling of well- being or calmness; and the substituent (D) that provides the short term psychological feedback is selected from the group consisting of: an anandamide; an alcohol enhancer; angelica root; balm; bitter orange ⁇ Auranti pericarpium); bogbean; boldo; calamus; California poppy; capsaicum; caraway; cayenne; chamomile; cinchona bark; quinine; chocolate; cinnamon; clove; cocoa; condurango; dandelion; elecampane; GABA; gentian; ginger; ginseng; holy thistle; hops; horehound; dried lemon peel ⁇ Citri pericardium); mugwort; unripe orange; peppermint; quassia; red sage; rosemary; star anise; thyme; tumeric; wormwood; yarrow; and zinc; and is present in an amount sufficient to provide a short term sensation of warmth,
- the invention additionally provides a composition for human consumption, comprising: at least one nutritionally beneficial substituent (A) selected from the group consisting of: gelatin; horsetail; silica; and bioavailable zinc; the substituent being present in an amount sufficient to enhance or facilitate hardening of fingernails; and at least one additional substituent, wherein the additional substituent is selected from the group consisting of a substituent (C) that provides long term psychological feedback substituent and a substituent (D) that provides short term psychological feedback; wherein the substituent (C) that provides the long term psychological feedback is selected from the group consisting of: an anandamide; 5-hydroxytryptophan; 5-fluoro-A- methyltryptamine; 5-fluorotryptophan; 6- fluorotryptophan; tryptophan; allocryptine; caffeine; theophylline; theobromine; California poppy; calcium; chromium picolinate; chromium polynicotinate; chicalote extract; cocoa; chocolate; Damiana ⁇ T
- Johnswort and is present in an amount sufficient to provide a long term feeling of well-being or calmness; and the substituent (D) that provides the short term psychological feedback is selected from the group consisting of: an anandamide; an alcohol enhancer; angelica root; balm; bitter orange ⁇ Auranti pericarpium); bogbean; boldo; calamus; California poppy; capsaicum; caraway; cayenne; chamomile; cinchona bark; quinine; chocolate; cinnamon; clove; cocoa; condurango; dandelion; elecampane; GABA; gentian; ginger; ginseng; holy thistle; hops; horehound; dried lemon peel ⁇ Citri pericardium); mugwort; unripe orange; peppermint; quassia; red sage; rosemary; star anise; thyme; tumeric; wormwood; yarrow; and zinc; and is present in an amount sufficient to provide a short term sensation of warmth,
- the invention also provides a method for hardening fingernails of a human, which comprises administering or providing to the human a composition comprising: at least one nutritionally beneficial substituent (A) selected from the group consisting of: gelatin; horsetail; silica; and bioavailable zinc; the substituent being present in an amount sufficient to enhance or facilitate hardening of fingernails of the human recipient; and at least one additional substituent, wherein the additional substituent is selected from the group consisting of a substituent (C) that provides long term psychological feedback substituent and a substituent (D) that provides short term psychological feedback; wherein the substituent (C) that provides the long term psychological feedback is selected from the group consisting of: an anandamide; 5-hydroxytryptophan; 5-fiuoro-A- methyltryptamine; 5-fluorotryptophan; 6- fluorotryptophan; tryptophan; allocryptine; caffeine; theophylline; theobromine; California poppy; calcium; chromium picolinate;
- Johnswort and is present in an amount sufficient to provide a long term feeling of well-being or calmness; and the substituent (D) that provides the short term psychological feedback is selected from the group consisting of: an anandamide; an alcohol enhancer; angelica root; balm; bitter orange ⁇ Auranti pericarpium); bogbean; boldo; calamus; California poppy; capsaicum; caraway; cayenne; chamomile; cinchona bark; quinine; chocolate; cinnamon; clove; cocoa; condurango; dandelion; elecampane; GABA; gentian; ginger; ginseng; holy thistle; hops; horehound; dried lemon peel ⁇ Citri pericardium); mugwort; unripe orange; peppermint; quassia; red sage; rosemary; star anise; thyme; tumeric; wormwood; yarrow; and zinc; and is present in an amount sufficient to provide a short term sensation of warmth,
- the invention additionally provides a composition for human consumption, comprising: at least two, at least three, or all, nutritionally beneficial substituents (A), wherein the substituents (A) are selected from the group consisting of: gelatin; horsetail; silica; and bioavailable zinc; wherein the substituents are present in an amount sufficient to enhance or facilitate hardening of fingernails.
- substituents (A) are selected from the group consisting of: gelatin; horsetail; silica; and bioavailable zinc; wherein the substituents are present in an amount sufficient to enhance or facilitate hardening of fingernails.
- the invention additionally provides a composition for human consumption, comprising: at least two, at least three, at least four, or at least five, substituents (B) that provide traditional psychological feedback, wherein the substituents (B) are selected from the group consisting of: caffeine or a caffeine equivalent; tryptophan; ephedra; cola; green tea extract; carbonic acid; phosphoric acid; citric acid; hops; cocoa; chocolate; an anandamide; quinine; malic acid; a sweetener; a fruit juice or fruit juice extract; milk; a vegetable juice or vegetable juice extract; and 5-hydroxy-tryptophan; wherein the substituents are present in an amount sufficient to provide a sensory psychological feedback.
- substituents (B) are selected from the group consisting of: caffeine or a caffeine equivalent; tryptophan; ephedra; cola; green tea extract; carbonic acid; phosphoric acid; citric acid; hops; cocoa; chocolate; an anandamide; quinine; malic acid; a sweet
- the invention additionally provides a composition for human consumption, comprising: at least two, at least three, at least four, or at least five, substituents (C) that provide long term psychological feedback, wherein the substituents (C) are selected from the group consisting of: an anandamide; 5-hydroxytryptophan; 5-fluoro-A- methyltryptamine; 5-fluorotryptophan; 6-fluorotryptophan; tryptophan; allocryptine; ⁇ ffeine; theophylline; theobromine;
- the invention additionally provides a composition for human consumption, comprising: at least two, at least three, at least four, or at least five, substituents (D) that provide short term psychological feedback, wherein the substituents (D) are selected from the group consisting of: an anandamide; an alcohol enhancer; angelica root; balm; bitter orange ⁇ Auranti pericarpium); bogbean; boldo; calamus; California poppy; capsaicum; caraway; cayenne; chamomile; cinchona bark; quinine; chocolate; cinnamon; clove; cocoa; condurango; dandelion; elecampane; GABA; gentian; ginger; ginseng; holy thistle; hops; horehound; dried lemon peel ⁇ Citri pericardium); mugwort; unripe orange; peppermint; quassia; red sage; rosemary; star anise; thyme; tumeric; wormwood; yarrow; and zinc; and wherein the
- the invention relates to formulated, defined compositions having a nutritionally beneficial substituent for hardening fingernails and a long and/or short term substituent that stimulates psychological feedback, optionally in combination with a substituent that provides a traditional psychological feedback.
- the invention further relates to vehicles or devices that accomplish the delivery of the composition to a recipient.
- the invention concerns such formulated, defined compositions that contain both a short term and a long term substituent that stimulates psychological feedback.
- compositions of the present invention are formulated or included in vehicles or devices that accomplish their delivery to recipients, and in particular, to recipient humans.
- Vehicles suitable for oral or translingual delivery are particularly preferred.
- a translingual delivery vehicle is one a that accomplishes the delivery of the composition via adsorbtion into the tongue, gums or soft tissues of the oral cavity.
- a vehicle suitable for oral delivery is one that accomplishes the delivery of the composition after ingestion.
- Oral and translingual/transdermal vehicles include beverages, lozenges, elixirs, syrups, powders, candies, chewable tablets, etc.
- the delivery of the compositions of the present invention is accomplished using a transdermal delivery device.
- Such devices include bandages, patches, implants, etc. that accomplish the delivery of substituents via adsorption through the skin.
- compositions of the present invention are said to be "formulated, defined compositions" by which it is meant that at least two, and preferably all, of their chemical substituents are substantially defined chemically.
- compositions of the present invention may contain undefined substituents, such as those found in naturally obtainable plant extracts, etc., in all instances they contain at least two chemically ascertainable substituents that were deliberately added to the composition in predetermined amounts to achieve preselected concentrations.
- amounts of such substituents in the compositions of the invention will preferably be determined with consideration of the beneficial concentration (potency) of the substituent.
- Beverages for oral administration are the preferred delivery vehicle.
- the term “beverage” is intended to refer to a liquid composition that is in "single” strength form and is ready to drink. Examples of beverage compositions are well known
- the invention contemplates the formulation and use of such beverages, as well as the formulation and use of beverage "concentrates.”
- concentrates include solid materials (capsules, tablets, powders, etc.) or solutions, suspensions, or other liquids that require dilution before attaining their desired final state.
- Such liquid compositions may be formulated from the dissolution or suspension of solid substituents, or from the mixing of liquid substituents, or both.
- the liquid compositions of the present invention are intended to be orally provided, as distinguished from intravenous or other means.
- the beverages of the present invention may be imbibed cooled (as by a refrigerant), or at ambient or elevated temperature (i.e., from about 25 °C to about 180 °C) or at more elevated temperatures (i.e., as a "hot' drink).
- the beverages of the present invention are imbibed at temperatures below 180 °C.
- the beverages of the present invention are imbibed at temperatures below 25 °C.
- the beverages of the present invention are preferably alcohol-free. They thus contain less than about 10% ethanol, more preferably less than about 5% ethanol, and most preferably are alcohol-free (i.e. only a trace amount of ethanol or none at all).
- the term "alcohol-free,” as used herein, is intended to be limited to consideration of the ethanol (ethyl alcohol) concentration of the beverage, and not to refer generally to concentrations of other non-ethanol alcohols that may be present.
- the beverages of the present invention may be alcohol-containing beverages (i.e., a beverage having between about 10% and about 20% alcohol).
- the beverages of the present invention may be either carbonated or non- carbonated.
- carbonated means that the beverage contains both dissolved and dispersed carbon dioxide.
- Methods of forming carbonated beverages are well known in the art (see, for example, U.S. Patent 4,946,701 (Tsai et al.).
- the beverages of the present invention will contain from 1.0 to about 4.5 volumes of carbon dioxide.
- the preferred carbon dioxide beverages contain from about 2 to about 3.5 volumes of carbon dioxide.
- compositions of the present invention contain at least one substituent selected from a first class of substituents that comprise nutritionally beneficial compounds for hardening fingernails. Any of a wide array of such substituents may be included in the compositions of the invention.
- the compositions of the present invention contain at least one, and more preferably 2 or more substituents of this first class. Preferred substituents of this first class, their associated function, and their preferred concentrations in the compositions of the present invention are described in Table A.
- a substituent is to be provided at a recited concentration, which is the preferred daily intake amount of the substituent. The daily intake amount may be obtained by a single serving, etc., or by multiple servings, etc.
- the daily intake amount will be delivered in three servings, each comprising one third of the total preferred intake amount.
- examples of typical serving sizes are any size between 1 and 16 fluid ounces (e.g., 16 ounces, 12 ounces, 8 ounces, 6 ounces, or 1 ounce) or metric equivalents.
- the amount/day shown is the most preferred amount per day, unless a maximum, more preferred and/or most preferred amount/day is indicated. Where no amount/day is provided, the substituent may be provided in any customary or traditional amount/day.
- the nutritionally beneficial substituent of the compositions of the invention will be selected from the group consisting of gelatin, horsetail, silica, and bioavailable zinc (or a zinc equivalent).
- This embodiment provides nutritional benefits including strengthening and hardening of fingernails.
- compositions of the invention may contain one or more such preferred nutritionally beneficial substituents, such more preferred substituents being selected from the group consisting of gelatin, horsetail, and silica.
- Highly Preferred Nutritionally Beneficial Substituents In a still more preferred embodiment, the compositions of the invention may contain one or more such preferred nutritionally beneficial substituents, such highly preferred substituents being selected from the group consisting of gelatin, and horsetail.
- composition of the invention may contain one or more additional nutritionally beneficial substituents.
- compositions of the invention may additionally contain at least one substituent selected from a second class of substituents that provide a traditional psychological feedback. Any of a wide array of such substituents may be included in the composition. Such substituents will impart a sensory psychological effect to the recipient, such as a pleasant taste, aroma, visual appeal, etc.
- the compositions of the invention may contain more than one such traditional psychological feedback substituent. Table B lists preferred traditional psychological feedback substituents that may be employed in the compositions of the present invention to impart such psychological effect.
- Caffeine and caffeine equivalents e.g., theophylline, theobromine, related methylxanthines
- Sweetener such as caloric sweeteners (e.g., fructose, high fructose com syrup, sucrose, maltose, glucose, lactose, sorbitol, galactose, etc.) or substantially non-caloric sweeteners (e.g., aspartame (and its derivatives), saccharin, L-sugars, cyclamates, etc.)
- caloric sweeteners e.g., fructose, high fructose com syrup, sucrose, maltose, glucose, lactose, sorbitol, galactose, etc.
- substantially non-caloric sweeteners e.g., aspartame (and its derivatives), saccharin, L-sugars, cyclamates, etc.
- Fruit juice or juice extract such as non-citrus fruit juices or juice extracts (e.g., those obtainable from apple, pineapple, grape, pear, banana, plum, cherry, peach, etc.); berry fruit juices or juice extracts (such as those obtainable from strawberry, blueberry, cranberry, blackberry, etc.); or citrus fruit juices or juice extracts (such as those obtainable from orange, grapefruit, lemon, lime, etc.)
- Milk including mammalian milk products such as skim milk and cream, and vegetable milks, such as soy milk.
- Vegetable juices or juice extracts (such as those obtainable from carrot, tomato, beets, celery, etc.)
- Spices and plant extract flavorings (such as cola, ginger, nutmeg, pepper, vanilla, chocolate, rum, mint, sugar maple, herbs, etc.).
- Synthetically compounded flavorants or naturally isolated flavorants may be employed.
- compositions of the present invention may be formulated to contain green tea extract.
- Green tea helps to control the negative effects of caffeine. See, for example, French patent No. 2,586,532 issued to Balansard etal.
- compositions of the present invention will contain one or more preferred traditional psychological feedback substituents, such more preferred substituents being selected from the group consisting of: Caffeine and caffeine equivalents (e.g., theophylline, theobromine, related methylxanthines); cola; carbonic acid; phosphoric acid; citric acid; hops; cocoa; chocolate; anandamide; quinine; malic acid; non-citric fruit juice or juice extract (such as wherein the fruit is grape, apple, cranberry, cherry, peach, etc.); milk; vegetable juice or juice extract (such as wherein the vegetable is carrot, celery, etc.); and 5-hydroxy-tryptophan.
- Caffeine and caffeine equivalents e.g., theophylline, theobromine, related methylxanthines
- cola carbonic acid
- phosphoric acid citric acid
- hops cocoa
- chocolate anandamide
- quinine malic acid
- non-citric fruit juice or juice extract such as wherein
- compositions of the present invention will contain one or more highly preferred traditional psychological feedback substituents, such highly preferred substituents being selected from the group consisting of: Caffeine and caffeine equivalents
- theophylline, theobromine, related methylxanthines at a concentration/day of greater than about 65 mg
- carbonic acid e.g., theophylline, theobromine, related methylxanthines
- hops e.g., the non-citric fruit juice or fruit juice extract (such as wherein the fruit is grape, apple, cranberry, cherry, peach, etc.); milk; vegetable juice or juice extract (such as wherein the vegetable is carrot, celery, etc.); and 5-hydroxy-tryptophan.
- compositions of the invention may additionally contain at least one substituent selected from a third class of substituents that provide long term psychological feedback. Any of a wide array of such substituents may be included in the composition. Such substituents will impart a long term psychological effect to the recipient, such as a feeling of warmth or tingling, of excitement, of tranquillity and well-being, etc. In a preferred embodiment, the compositions of the invention will contain more than one such long term psychologically active substituent. Table C lists particularly preferred long term duration psychological feedback substituents that may be employed in the compositions of the present invention to impart a long term psychological effect.
- compositions of the present invention will contain one or more such long term psychological feedback substituents, such more preferred substituents being selected from the group consisting of: 5-hydroxytryptophan or equivalent compounds (e.g., 5- fluoro-A-methyltryptamine, 5-fluorotryptophan, 6-fluorotryptophan, tryptophan, etc.); Allocryptine; California Poppy; Chromium (Cr-Picolinate; Cr-Polynicotinate; (Cr amounts increased with amount of Zn present, decreased for amounts of amino acids)); Cocoa; Damiana ⁇ Turnera diffusa); D-phenylalanine; Ephedra (especially nevadenis); Ephedrine; Epinephrine; GABA; L-glutamine; Green Tea; Kava Kava; Lactuca Virosa; Lobelia;
- 5-hydroxytryptophan or equivalent compounds e.g., 5- fluoro-A-methyltryptamine, 5-fluorotryptophan, 6-fluor
- compositions of the present invention will contain one or more such long term psychological feedback substituents, such highly preferred substituents being selected from the group consisting of: 5-hydroxytryptophan or equivalent compounds (e.g., 5-fluoro-A-methyltryptamine, 5-fluorotryptophan, 6-fluorotryptophan, tryptophan, etc.); Allocryptine; California Poppy; Chicalote Extract (without toxic substituents); Cocoa; Damiana (Turnera diffusa); Ephedra nevadenis; Ephedrine; Green Tea; Lactuca Virosa; Lobelia; Maraba; Protopine; Pseudophedrine; Pseudoepinephrine and
- compositions of the invention may additionally contain at least one substituent selected from a fourth class of substituents that provide short term psychological feedback. Any of a wide array of such substituents may be included in the composition. Such substituents will impart a short term psychological effect to the recipient, such as a feeling of warmth or tingling, of excitement, of tranquillity and well- being, etc. In a preferred embodiment, the compositions of the invention will contain more than one such short term psychologically active substituent.
- compositions of the invention will contain psychologically active substituents that mediate their respective effects in both a short duration (i.e., effect completed within 15 minutes of nutritionally beneficial.) and a long term duration (i.e., effect completed after 15 minutes of nutritionally beneficial).
- Table D lists preferred short term duration psychological feedback substituents that may be employed in the compositions of the present invention to impart a short term psychological effect.
- compositions of the present invention will contain one or more preferred short term psychological feedback substituents, such more preferred substituents being selected from the group consisting of: Anandamide; Alcohol Enhancers,
- compositions of the present invention will contain one or more highly preferred short term psychological feedback substituents, such highly preferred substituents being selected from the group consisting of: an anandamide; an alcohol enhancer; Angelica root; Boldo; California Poppy; Capsaicum; GABA; Gentian; Tumeric; Vitamin K; and Wormwood.
- highly preferred substituents being selected from the group consisting of: an anandamide; an alcohol enhancer; Angelica root; Boldo; California Poppy; Capsaicum; GABA; Gentian; Tumeric; Vitamin K; and Wormwood.
- compositions containing one or more substituents of substituent classes (A) that provide nutritional benefit for hardening fingernails, (B) that provide traditional psychological feedback, (C) that provide long term psychological feedback, and/or (D) that provide short term psychological feedback.
- substituent classes (A), (B), (C) and (D); (A), (B) and (C); (A), (B) and (D); (A), (C) and (D); (B), (C) and (D); (A) and (B);
- compositions containing: one or more of the above-recited preferred nutritionally beneficial substituents (A), one or more of the above-recited preferred long term psychological feedback substituents (C), and one or more of the above-recited preferred short term psychological feedback substituents (D).
- the invention additionally contemplates preferred compositions containing either one or more of the above-recited more preferred nutritionally beneficial substituents (A) or one or more of the above-recited highly preferred nutritionally beneficial substituents (A), and one or more of the above-recited preferred long term psychological feedback substituents (B), and one or more of the above-recited preferred short term psychological feedback substituents (C).
- the invention additionally contemplates preferred compositions containing one or more of the above-recited preferred nutritionally beneficial substituents (A), and one or more of the above-recited preferred long term psychological feedback substituents (C), and either one or more of the above-recited more preferred short term psychological feedback substituents (D) or one or more of the above-recited highly preferred short term psychological feedback substituents (D).
- the invention additionally contemplates preferred compositions containing one or more of the above-recited preferred nutritionally beneficial substituents (A), and either one or more of the above-recited more preferred long term psychological feedback substituents (C) or one or more of the above-recited highly preferred long term psychological feedback substituents (C), and one or more of the above-recited preferred short term psychological feedback substituents (D).
- the invention further contemplates more preferred compositions containing one or more of the above-recited more preferred nutritionally beneficial substituents (A), and one or more of the above-recited preferred long term psychological feedback substituents (C), and one or more of the above-recited more preferred short term psychological feedback substituents (D).
- the invention further contemplates more preferred compositions containing one or more of the above-recited preferred nutritionally beneficial substituents (A), and one or more of the above-recited more preferred long term psychological feedback substituents (C), and one or more of the above-recited more preferred short term psychological feedback substituents (D).
- the invention further contemplates highly preferred compositions containing one or more of the above-recited highly preferred nutritionally beneficial substituents (A), and one or more of the above-recited preferred long term psychological feedback substituents (C), and one or more of the above-recited highly preferred short term psychological feedback substituents (D).
- the invention further contemplates highly preferred compositions containing one or more of the above-recited highly preferred nutritionally beneficial substituents (A), and one or more of the above-recited highly preferred long term psychological feedback substituents (C), and one or more of the above-recited preferred short term psychological feedback substituents (D).
- the invention further contemplates highly preferred compositions containing one or more of the above-recited preferred nutritionally beneficial substituents (A), and one or more of the above-recited highly preferred long term psychological feedback substituents (C), and one or more of the above-recited highly preferred short term psychological feedback substituents (D).
- the invention further contemplates very highly preferred compositions containing one or more of the above-recited highly preferred nutritionally beneficial substituents (A), and one or more of the above-recited highly preferred long term psychological feedback substituents (C), and one or more of the above-recited highly preferred short term psychological feedback substituents (D).
- compositions of the present invention may additionally contain non-pharmacological agents such as stomach acid buffering compounds, antacids, fiber, laxatives, muscle relaxants, analgesics, acetaminophens, ibuprophens, topical antibiotics, anti-inflammatory agents, etc.) at non-prescription levels.
- non-pharmacological agents such as stomach acid buffering compounds, antacids, fiber, laxatives, muscle relaxants, analgesics, acetaminophens, ibuprophens, topical antibiotics, anti-inflammatory agents, etc.
- prescription pharmacological agents such as hormones (e.g., insulin, thyroid hormone, etc.), anti-inflammatory agents, hypertensives, anti-arrhythmias, etc.
- compositions of the present invention and such prescription pharmacological agents has the salutary effect of confirming or the consumer's perception or recollection that a dosage has been consumed or administered, and as such aids in preventing overdosing and underdosing by individuals who are self administering such pharmacological agents.
- the compositions of the present invention are provided via vehicles for oral or translingual delivery.
- such vehicles are formulated to contain one or more additional substituents selected from the group consisting of: a xanthine alkaloid (such as a methylxanthine (caffeine, theophylline, theobromine, etc.) obtainable synthetically, or by extraction of plants (e.g. coffee beans, cola nuts, tea plants, etc.); carbonic acid, milk, vegetable juice, fruit juice, phosphoric acid, citric acid, hops, cocoa, chocolate, anandamide, quinine and malic acid.
- a xanthine alkaloid such as a methylxanthine (caffeine, theophylline, theobromine, etc.
- plants e.g. coffee beans, cola nuts, tea plants, etc.
- carbonic acid e.g. coffee beans, cola nuts, tea plants, etc.
- carbonic acid e.g. coffee beans, cola nuts, tea plants, etc.
- carbonic acid e.g. coffee beans, cola nuts, tea plants
- the amounts of methylxanthines (and especially caffeine) present in the compositions of the invention are designed to result in the delivery of an amount of such methylxanthines sufficient to impart the desired effect.
- the composition contain compounds that interact (or sequester) such methylxanthines, proportionately larger amounts of methylxanthine will be included in the composition.
- the composition contain substituents that enhance the desired effect of a methylxanthine, the amount of the methylxanthine in the composition will be proportionately reduced.
- Serotonin, and its precursors, and substituents that stimulate serotonin production and/or release are also preferred substituents of the compositions of the present invention.
- compositions of the present invention may comprise clear solutions, or may be suspensions of particulate material (such as plant pulp or other tissue).
- particulate material such as plant pulp or other tissue.
- beverages When provided as a beverage, such beverages are typically free-flowing and have a viscosity similar to that of water.
- thickening agents are added to impart greater viscosity to the beverages.
- the beverages of the present invention are typically dispensed and stored in containers (e.g., cardboard containers, glass or plastic bottles, metal cans, etc.).
- compositions of the present invention provide a nutritionally beneficial substituent to an individual in a manner accompanied by a reinforcing psychological feedback sensation.
- the psychological feedback sensation imparts an immediate physiological recognition of the composition (such as a feeling of warmth, or a flush feeling) as well as a long term psychological feedback (such as a counter-depressive effect or a sense of well-being).
- These feedbacks become psychologically associated with the nutritional benefit of the composition and increase an individual's desire to take or use the composition on a regular basis, and thus serve to ensure that the individual obtains a nutritionally beneficial amount of the composition.
- the compositions of the present invention can be tailored to provide any of a number of desired therapeutic effects.
- Such effects include blood detoxification; liver repair and detoxification; lessening of a desire to drink alcohol; reversal of alcohol-induced damage; antioxidant activity; alleviating depression, alleviating stress, restoring or improving brain function (such as memory and learning capabilities); suppressing appetite; stabilizing blood sugar levels; improving immune system function and response; etc.
- such compositions can be formulated to contain effective amounts of nutritionally active substituents (such as vitamins, minerals, co-factors, etc.) which build or restore supplies of such substituents damaged by conditions commonly related to each therapy so as to improve the general health of the recipient.
- compositions of the present invention are formulated to provide a treatment for the conditions associated with alcoholism.
- Such compositions, especially beverages are formulated to provide effective amounts of: (1) a liver function repairant (such as alfalfa, choline, dandelion, gotu kola, inositol, L-cysteine, L-methionine, lecithin, milk thistle, niacin, selenium, vitamin Bl, vitamin D, yellow dock, zinc and or zinc picolinate); (2) a substituent for reversing alcohol-related damage (alfalfa, magnesium, vitamin Bl, vitamin D); (3) a substituent for alleviating stress or depression (such as calcium, choline, folic acid, GABA, ginkgo biloba, ginseng, gotu kola, inositol, DL- phenylalanine, 5-hydroxy-tryptophan, lecithin, magnesium, PABA, vitamin B3, vitamin B5, vitamin B
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Botany (AREA)
- Inorganic Chemistry (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Non-Alcoholic Beverages (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU49848/99A AU4984899A (en) | 1998-07-14 | 1999-07-13 | Nutritionally active composition for hardening fingernails |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11523098A | 1998-07-14 | 1998-07-14 | |
US09/115,230 | 1998-07-14 | ||
US20929098A | 1998-12-11 | 1998-12-11 | |
US09/209,290 | 1998-12-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2000003679A2 true WO2000003679A2 (en) | 2000-01-27 |
Family
ID=26812980
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1999/015669 WO2000003679A2 (en) | 1998-07-14 | 1999-07-13 | Nutritionally active composition for hardening fingernails |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU4984899A (en) |
WO (1) | WO2000003679A2 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8318214B2 (en) | 2003-06-23 | 2012-11-27 | Polichem S.A. | Method for treating onychoschizia |
US10519175B2 (en) | 2017-10-09 | 2019-12-31 | Compass Pathways Limited | Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use |
US11564935B2 (en) | 2019-04-17 | 2023-01-31 | Compass Pathfinder Limited | Method for treating anxiety disorders, headache disorders, and eating disorders with psilocybin |
US11724985B2 (en) | 2020-05-19 | 2023-08-15 | Cybin Irl Limited | Deuterated tryptamine derivatives and methods of use |
-
1999
- 1999-07-13 WO PCT/US1999/015669 patent/WO2000003679A2/en not_active Application Discontinuation
- 1999-07-13 AU AU49848/99A patent/AU4984899A/en not_active Withdrawn
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8318214B2 (en) | 2003-06-23 | 2012-11-27 | Polichem S.A. | Method for treating onychoschizia |
US11851451B2 (en) | 2017-10-09 | 2023-12-26 | Compass Pathfinder Limited | Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use |
US10519175B2 (en) | 2017-10-09 | 2019-12-31 | Compass Pathways Limited | Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use |
US10947257B2 (en) | 2017-10-09 | 2021-03-16 | Compass Pathfinder Limited | Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use |
US10954259B1 (en) | 2017-10-09 | 2021-03-23 | Compass Pathfinder Limited | Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use |
US11149044B2 (en) | 2017-10-09 | 2021-10-19 | Compass Pathfinder Limited | Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use |
US11180517B2 (en) | 2017-10-09 | 2021-11-23 | Compass Pathfinder Limited | Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use |
US11447510B2 (en) | 2017-10-09 | 2022-09-20 | Compass Pathfinder Limited | Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use |
US11505564B2 (en) | 2017-10-09 | 2022-11-22 | Compass Pathfinder Limited | Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use |
US11629159B2 (en) | 2017-10-09 | 2023-04-18 | Compass Pathfinder Limited | Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use |
US11939346B2 (en) | 2017-10-09 | 2024-03-26 | Compass Pathfinder Limited | Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use |
US11564935B2 (en) | 2019-04-17 | 2023-01-31 | Compass Pathfinder Limited | Method for treating anxiety disorders, headache disorders, and eating disorders with psilocybin |
US11738035B2 (en) | 2019-04-17 | 2023-08-29 | Compass Pathfinder Limited | Method for treating anxiety disorders, headache disorders, and eating disorders with psilocybin |
US11746088B2 (en) | 2020-05-19 | 2023-09-05 | Cybin Irl Limited | Deuterated tryptamine derivatives and methods of use |
US11834410B2 (en) | 2020-05-19 | 2023-12-05 | Cybin Irl Limited | Deuterated tryptamine derivatives and methods of use |
US11724985B2 (en) | 2020-05-19 | 2023-08-15 | Cybin Irl Limited | Deuterated tryptamine derivatives and methods of use |
US11958807B2 (en) | 2020-05-19 | 2024-04-16 | Cybin Irl Limited | Deuterated tryptamine derivatives and methods of use |
Also Published As
Publication number | Publication date |
---|---|
AU4984899A (en) | 2000-02-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20010008641A1 (en) | Nutritionally active composition for bodybuilding | |
WO1999061038A1 (en) | Composition having therapeutic and/or nutritionally active substituent | |
US20130015204A1 (en) | Single-use containers and uses thereof | |
US11134710B2 (en) | Cannabinoid emulsion product and process for making the same | |
US20060134300A1 (en) | Nutritional supplement for caffeine-containing beverages | |
US7476406B1 (en) | Multifaceted weight control system | |
US20060134181A1 (en) | Novel chocolate composition as delivery system for nutrients and medications | |
US20060110478A1 (en) | Delivery system and method for supporting and promoting healthy sexual function and prevention and treatment of sexual dysfunction | |
JP6519882B2 (en) | Use of tryptophan rich protein hydrolysates | |
US20160213624A1 (en) | Composition, Commericial Product and Method for Treating Cannabis Toxicity | |
US8507015B2 (en) | Composition for countering the effects of alcohol consumption | |
US20200077678A1 (en) | Nutritionally Premium Cola Carbonated Soft Drink - Composition, Method of Preparation and Applications | |
US20060110477A1 (en) | Composition and method for supporting and promoting healthy sexual function and prevention and treatment of sexual dysfunction | |
WO2000003679A2 (en) | Nutritionally active composition for hardening fingernails | |
US20030148016A1 (en) | Energy fitness water | |
US20060094734A1 (en) | Composition and method for inducing alertness | |
CA2810793C (en) | Sphaeranthus indicus derived ingredients and their compositions for enhancing physical performance and energy levels | |
US20120294952A1 (en) | Antitussive compositions and methods | |
TW202227085A (en) | Deuterated paraxanthine and uses thereof | |
US20220295853A1 (en) | Loaded granules, their process of production and their uses | |
US20050053555A1 (en) | Appetite control compositions and methods of use | |
WO2014133562A1 (en) | Dry powdered comestibles and packaging therefor | |
Pant et al. | Flavoring of Pediatric Nutritional Supplements and Pediatric Compliance: A Perspective | |
AU2020465484A1 (en) | Caffeinated botanical infusion beverage and method of making same | |
AU2015234318A1 (en) | Single-use containers and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WA | Withdrawal of international application | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |